Skip to content

ALINE SCHOTTE PHARMA

Active Risk: moderate
Limited partnershipfounded 2025active for 1 yearMeenseweg 224, 8900 Ypres, BelgiumKBO/BCE: BE 1020.875.015
Risk analysisFollow ReportCompare
ALINE SCHOTTE PHARMAActive
Risk analysis ReportCompare

Directors

Directors
1 director, since incorporation
Aline SCHOTTE
Manager · appointed by deed of 13-03-2025 · term for the life of the company
Current
Office holders in the KBO →
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“(b) Bestuursbevoegdheid De enige zaakvoerder en in het geval er meerdere zijn, elke zaakvoerder afzonderlijk optredend, heeft de meest…”
deed of 13-03-2025

Owners and capital

Shareholders

At incorporation deed of 13-03-2025 ↗
  • Aline SCHOTTE gecommanditeerde vennoot · 99 shares (100%) · €99 in cash

Capital transactions

Capital over time
  1. 20-06-2025 Capital stated in the deed · €100 · 100 shares
  2. 13-03-2025 Incorporation · €99 · 99 shares

Articles of association

Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
99 shares
1 share

Articles of association, deed of 20-06-2025 (in Dutch)

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure